Cargando…

TP53 loss creates therapeutic vulnerability in colorectal cancer

TP53 , a well-known tumour suppressor gene, is frequently inactivated by mutation or deletion in a majority of human tumours(1,2). A tremendous effort has been made to restore p53 activity in cancer therapies(3–7). However, no effective p53-based therapy has been successfully translated into clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yunhua, Zhang, Xinna, Han, Cecil, Wan, Guohui, Huang, Xingxu, Ivan, Cristina, Jiang, Dahai, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Rao, Pulivarthi H., Maru, Dipen M., Pahl, Andreas, He, Xiaoming, Sood, Anil K., Ellis, Lee M., Anderl, Jan, Lu, Xiongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417759/ https://www.ncbi.nlm.nih.gov/pubmed/25901683 http://dx.doi.org/10.1038/nature14418

Ejemplares similares

Amplification of USP13 drives ovarian cancer metabolism
por: Han, Cecil, et al.
Publicado: (2016)

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
por: Elsayed, Abdelrahman M., et al.
Publicado: (2021)

Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II
por: Li, Yujing, et al.
Publicado: (2018)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
por: Wang, Enfeng, et al.
Publicado: (2011)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Neuropilin-2 Mediated β-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines
por: Samuel, Shaija, et al.
Publicado: (2011)

TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies
por: Wilkie, Mark D., et al.
Publicado: (2020)

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
por: Tseng, Jill H., et al.
Publicado: (2017)

Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
por: Amero, Paola, et al.
Publicado: (2020)

Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
por: Szymanowska, Anna, et al.
Publicado: (2023)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016)

Neurobiology of opioid dependence in creating addiction vulnerability
por: Evans, Christopher J., et al.
Publicado: (2016)

Sims and Vulnerability: On the Ethics of Creating Emulated Minds
por: Chomanski, Bartlomiej
Publicado: (2022)

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2019)

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2022)

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
por: Yang, Lifeng, et al.
Publicado: (2014)

Targeting KRas-dependent tumor growth, circulating tumor cells and metastasis in vivo by clinically significant miR-193a-3p
por: Seviour, Elena G., et al.
Publicado: (2016)

Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
por: Ajore, Ram, et al.
Publicado: (2017)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
por: Liu, Yunhua, et al.
Publicado: (2018)

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
por: Kanlikilicer, Pinar, et al.
Publicado: (2018)

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]
por: Kanlikilicer, Pinar, et al.
Publicado: (2020)

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
por: Bayraktar, Emine, et al.
Publicado: (2023)

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
por: Szymanowski, Wojciech, et al.
Publicado: (2023)

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer
por: Martinez-Castillo, Moises, et al.
Publicado: (2023)

Creating and Evaluating Two Cumulative Developmental Vulnerability Risk Measures.
por: Duku, Eric, et al.
Publicado: (2022)

Accessibility of covariance information creates vulnerability in Federated Learning frameworks
por: Huth, Manuel, et al.
Publicado: (2023)

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer
por: Rabinowicz, Noa, et al.
Publicado: (2017)

Dynamic HIV-1 spike motion creates vulnerability for its membrane-bound tripod to antibody attack
por: Yang, Shuang, et al.
Publicado: (2022)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)

Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer
por: Chakraborty, Debaditya, et al.
Publicado: (2021)

Absence of Wip1 partially rescues Atm deficiency phenotypes in mice
por: Darlington, Yolanda, et al.
Publicado: (2011)

A rare case of pancreatic metastasis of angiosarcoma: Diagnosed by endoscopic ultrasound-guided fine-needle aspiration and biopsy
por: Bhutani, Manoop S., et al.
Publicado: (2017)

Exploratory study of macrophage polarization and spatial distribution in colorectal cancer liver metastasis: a pilot study
por: Khanduri, Isha, et al.
Publicado: (2023)

Back to the Future: Rethinking the Great Potential of lncRNA(S) for Optimizing Chemotherapeutic Response in Ovarian Cancer
por: Elsayed, Abdelrahman M., et al.
Publicado: (2020)

microRNA Therapeutics in Cancer — An Emerging Concept
por: Shah, Maitri Y., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7mgoqfgq6h0nc26rd36pnefni2